Joseph Monahan
Technik-/Wissenschafts-/F&E-Leiter bei ACLARIS THERAPEUTICS, INC.
Vermögen: 222 501 $ am 30.04.2024
Aktive Positionen von Joseph Monahan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | 01.01.2010 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | - | |
| Gründer | 01.01.2010 | - |
Karriereverlauf von Joseph Monahan
Ehemalige bekannte Positionen von Joseph Monahan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Joseph Monahan
| State University of New York at Buffalo | Undergraduate Degree |
| University of South Carolina | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Börse
- Insiders
- Joseph Monahan
- Erfahrung
